BERKELEY FIAL: Open Payments
NPI 1124513981 · BOULDER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,683 in 82 payments from 17 companies in 2025. Trend: 2023 $1,652 · 2024 $3,220 · 2025 $2,683
Food & beverage: $2,528Education: $155
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $413 |
| Janssen Biotech, Inc. | 11 | $323 |
| Organon LLC | 7 | $280 |
| ABBVIE INC. | 10 | $252 |
| LEO Pharma Inc. | 7 | $227 |
| Amgen Inc. | 3 | $225 |
| E.R. Squibb & Sons, L.L.C. | 4 | $171 |
| Galderma Laboratories, L.P. | 7 | $161 |
| Arcutis Biotherapeutics, Inc. | 8 | $159 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $125 |
Products named: DUPIXENT, TREMFYA, VTAMA, Otezla, ADBRY, SKYRIZI, Sotyktu, Zoryve.
Industry payments across CO — which companies pay providers there.
